Loading clinical trials...
Loading clinical trials...
Phase II Open-label Single Arm Study of Oxaliplatin Combined With Cisplatin and 5FU in Advanced Esophagus Cancer Patients
Conditions
Interventions
Oxaliplatin + cisplatin + 5-Fluorouracil (5-FU)
Locations
1
Spain
Sanofi-Aventis Administrative Office
Barcelona, Spain
Start Date
February 1, 2000
Primary Completion Date
October 1, 2008
Completion Date
October 1, 2008
Last Updated
December 7, 2009
NCT07035587
NCT05688176
NCT05624099
NCT06027515
NCT06381583
NCT05680077
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions